Presumed ICMS Credit under STJ Theme 1.182.
Re-trial, risks and strategy for companies.

What STJ Theme 1.182 is

Original 2023 decision (1st Section)

Theme 1.182 was decided by the STJ’s 1st Section in 2023, with Justice Benedito Gonçalves as rapporteur. The thesis set established that presumed ICMS credits CANNOT be excluded from the IRPJ and CSLL calculation base, unless the requirements of Complementary Law 160/2017 and art. 30 of Law 12.973/2014 (investment subsidy) are met. The decision changed the consolidated reading from EREsp 1.517.492 (2017) — creating legal uncertainty for companies that adopted the earlier interpretation.

Distinction between presumed credit and other ICMS benefits

Theme 1.182 deals specifically with presumed credits — a modality in which the state grants the taxpayer a fictitious ICMS credit to offset the debit (e.g., an industry that buys an input without ICMS receives a presumed credit as if it had paid). Other ICMS benefits (reduced rate, exemption, base reduction) follow their own rules, not directly affected by Theme 1.182.

Relevance of EREsp 1.517.492 (2017)

EREsp 1.517.492 (1st Section, 2017) held that presumed ICMS credits do not form part of the IRPJ/CSLL base — arguing that federal taxation of a state benefit would violate the federative pact (art. 150 §6 of the Constitution) and the reciprocal-immunity principle. This interpretation prevailed for six years and was partially revised in 2023.

Why the STJ will re-try in 2026

Allocation of new appeals in 2026

After the 2023 decision, new appeals were allocated to the repetitive-appeals procedure by the STJ’s 1st Section. The current rapporteur is Justice Regina Helena Costa — a reference in tax matters and rapporteur of relevant ICMS theses. The re-trial addresses nuances not exhausted in 2023, in particular the interaction with Law 14.789/2024 (which replaced Law 12.973/2014).

The rapporteur’s vote and timeline

Justice Regina Helena Costa’s vote will be decisive. There is a technical expectation that the rapporteur will propose a refinement of the thesis, with clearer criteria to distinguish eligible presumed credits (which can be excluded from the base) from non-eligible ones. The exact timeline depends on the 1st Section’s agenda, with completion expected during 2026.

Impacts of the re-trial

Regardless of the outcome, the re-trial brings greater clarity on the treatment of presumed credits after Law 14.789/2024. Companies with relevant state benefits need to follow the trial and map scenarios — especially because Law 14.789 substantially modified the subsidy regime, eliminating the distinction between investment subsidy and cost subsidy for tax purposes.

Re-trial scenarios and probabilities

Scenario 1 — Maintain current case law (exclusion)

The STJ may reaffirm the original understanding of EREsp 1.517.492 (2017), with an express thesis that presumed ICMS credits do NOT form part of the IRPJ/CSLL base — regardless of classification as an investment subsidy. A favorable scenario for companies with relevant state benefits. Estimated technical probability: 30-40%.

Scenario 2 — Reversal (include in the base)

The STJ may set a thesis that presumed credits form part of the IRPJ/CSLL base, except when strictly classified under the requirements of CL 160/2017 and Law 14.789/2024. An unfavorable scenario for companies. In a reversal, the retroactive liability can be substantial — especially for industries with long-term SUDENE/SUDAM/Manaus FTZ benefits. Estimated technical probability: 30-40%.

Scenario 3 — Modulation of effects with time cut-offs

The scenario with the highest technical probability (30-40%): the STJ confirms the reversal but modulates effects, restricting the new thesis to events after the decision. Companies that used the favorable interpretation until 2023 are protected. Modulation is frequent in decisions with strong fiscal impact and was the technique used in other relevant tax themes (STF Theme 69 — exclusion of ICMS from the PIS/COFINS base).

Which companies are exposed

Sectors with relevant presumed credit

Sectors with the greatest exposure to presumed ICMS credits in Brazil:

• Consumer-goods industry — food, beverages, textiles, cosmetics with state benefits
• Pharmaceutical industry — PRODEPE (PE), INVESTE-MG, INVESTE-SP benefits
• Agribusiness — agricultural processing and animal-protein processing
• Pulp and paper industry — SUDAM and SUDENE benefits
• Automotive industry — state benefits for assemblers
• Manaus companies — Free Trade Zone with a specific regime

States with active presumed-credit regimes

States with relevant presumed-credit incentive programs: Pernambuco (PRODEPE), Bahia (DESENVOLVE), Minas Gerais (FINOR/INVESTE-MG), São Paulo (INVESTE-SP), Goiás (FOMENTAR/PRODUZIR), Mato Grosso (PRODEIC), Pará and Amazonas (regional regimes), plus the SUDENE/SUDAM benefits in the northeast and north. Law 14.789/2024 changed the federal treatment of these benefits — generating current challenges.

Exposure estimate by size

For an industry with revenue of BRL 200 million annually and a presumed credit equivalent to 5% of taxable purchases, the estimated annual saving is BRL 1-3 million per year. Over five years, the potential retroactive liability in a reversal scenario reaches BRL 5-15 million. For large industrial groups with higher volume, exposure can reach BRL 50-200 million.

How to map your exposure now

Digital tax audit over the last 5 years

The starting point is a digital tax audit of the last five years — a complete reading of SPED-Fiscal, EFD-Contribuições, ECF and ECD. Identification of the presumed credits actually used, the associated asset value and the accounting/tax treatment adopted by the company in each year.

Required documentation — CL 160/2017 and Law 12.973/2014

Critical documents for the analysis: (i) the CONFAZ agreements that authorized the state benefit; (ii) the adhesion terms to the state program; (iii) usage reports of the presumed credit over the five years; (iv) balance sheets showing the investment-subsidy reserve (art. 30 of Law 12.973/2014, before Law 14.789); (v) technical reports on the allocation of resources to investment (where applicable).

Calculating the asset impact in a reversal scenario

Quantitative modeling with three variables: (i) the retroactive liability — the IRPJ/CSLL not collected over the previous five years in case of a reversal without modulation; (ii) the prospective liability — additional IRPJ/CSLL from the final decision; (iii) the interest and penalties applicable in case of retroactive collection by the Revenue. The exercise generates realistic scenarios and allows a technical decision on a preventive strategy.

Defensive and offensive strategy

Preventive action before the re-trial

Companies with material exposure to Theme 1.182 may file a preventive writ of mandamus or a declaratory action before the STJ’s final decision. The goal: to secure a favorable interpretation applicable to the years before the ruling, with protection against a partial modulation. A relatively low procedural cost compared to the potential liability.

Use of alternative tax benefits (CL 160/2017)

CL 160/2017 established a specific procedure for validating state benefits as an investment subsidy — validation of the benefits by the states, accounting registration in a specific reserve and application of the resources to fixed assets. Companies that meet all the requirements can keep the exclusion of presumed credits from the base even in a Theme 1.182 reversal scenario. The technical analysis of classification requires a specific reading of each state program.

Corporate restructuring to mitigate exposure

In some cases, corporate restructuring can reduce exposure: (i) a spin-off of the beneficiary legal entity, segregating activities with and without presumed credits; (ii) an intermediate holding for optimized accounting/tax treatment; (iii) a regime migration (Actual vs Presumed Profit) considering the impact of Law 14.789. Each structure has its complexity and requires individual analysis.

How the firm acts in Theme 1.182 cases

EREsp 1.517.492 eligibility diagnosis

The starting point is a technical reading of the benefits used by the company over the last five years. Validation of whether they meet the requirements of EREsp 1.517.492 (2017) and CL 160/2017 — validation by the states, adequate accounting registration, application of resources. The diagnosis classifies the level of exposure and defines the recommended strategy.

Action for the repetition of undue payment (pre-2023 periods)

For companies that paid IRPJ/CSLL on presumed credits before the 2023 decision — following a conservative tax orientation — there may be a right to retroactive repetition of undue payment, considering EREsp 1.517.492 as precedent. The analysis considers the five-year limitation period and the supporting documentation.

Preventive writ of mandamus (post-re-trial periods)

For companies with relevant prospective exposure, a preventive writ of mandamus secures the application of the favorable interpretation regardless of the STJ’s final decision — provided it is filed before the re-trial. The measure protects against a partial modulation and keeps the company in a safe position during the window of legal uncertainty.